Helmholtz Centre for Infection Research
10
2
4
5
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
Moderate Risk
Score: 45/100
0.0%
0 terminated/withdrawn out of 10 trials
100.0%
+13.4% vs industry average
0%
0 trials in Phase 3/4
0%
0 of 5 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (10)
D-SOLVE Cohorts (Cohort A and B)
Role: collaborator
LoewenKIDS - Infections and the Development of the Immune System
Role: lead
Psychosomatic, Physical Activity or Both for Post-covid19 Syndrom
Role: collaborator
Clostridioides Difficile Controlled Human Infection Model
Role: collaborator
Effect of Dietary Supplements on the Oral Microbiome
Role: collaborator
The Transplant Cohort of the German Center for Infection Research
Role: collaborator
Evaluation of CDSS in Detection of SIRS and Sepsis in Pediatric Patients
Role: collaborator
Systems Medicine to Study Necrotizing Soft Tissue Infections (NSTIs).
Role: collaborator
Influenza Vaccination Among the Elderly Individuals
Role: lead
The Investigation of Methods to Capture Acute Respiratory and Gastrointestinal Infections of Children Aged 1 to 3 Years
Role: lead
All 10 trials loaded